Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy shows promise for tough pancreatic cancers

NCT ID NCT02676349

Completed Disease control Sponsor: Institut de Cancérologie de Lorraine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different treatment plans for people with a specific type of pancreatic cancer that is on the edge of being removable by surgery. 130 patients received either chemotherapy alone or chemotherapy plus radiation before surgery. The goal was to see which approach leads to a better chance of completely removing the tumor and improving outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

exocrine pancreatic carcinoma pancreatic adenocarcinoma pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CARCINOMA

Contacts and locations

Locations

  • CHP Saint Grégoire

    Saint-Grégoire, France

  • CHU Reims

    Reims, France

  • Centre Eugène Marquis

    Rennes, France

  • Centre Oscar Lambret

    Lille, France

  • Chru Lille

    Lille, France

  • Chru Nancy

    Vandœuvre-lès-Nancy, France

  • Chru Tours

    Tours, France

  • Chu Colmar

    Colmar, France

  • Chu Nantes

    Nantes, France

  • Chu Rouen

    Rouen, France

  • Hôpital Beaujon

    Clichy, 92110, France

  • Hôpital Cochin (APHP)

    Paris, France

  • Hôpital Européen Marseille

    Marseille, France

  • Hôpital Haut-Lévêque

    Pessac, France

  • Hôpital Henri Mondor (APHP)

    Créteil, France

  • Hôpital La Timone

    Marseille, France

  • Hôpital Paul Brousse

    Villejuif, 94804, France

  • Infirmerie Protestante de Lyon

    Lyon, France

  • Institut Bergonié

    Bordeaux, France

  • Institut Mutualiste Montsouris

    Paris, France

  • Institut Paoli CALMETTES

    Marseille, France

  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, France

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, France

  • Institut du Cancer de Montpellier

    Montpellier, France

  • Pitié Salpêtrière (APHP)

    Paris, France

  • Polyclinique Bordeaux Nord

    Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.